Update on the management of connective tissue malignanciesFANUCCHI, Michael.Seminars in oncology. 2004, Vol 31, Num 2, pp 16-19, issn 0093-7754, 4 p., SUP4Conference Paper

Clear cell carcinoma of the ovary : A remarkable caseGIBLIN, Joan; FANUCCHI, Michael P; MCGUIRE, William P et al.American journal of clinical oncology. 2001, Vol 24, Num 1, pp 99-100, issn 0277-3732Article

Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomasMAKI, Robert G; WATHEN, J. Kyle; THALL, Peter F et al.Journal of clinical oncology. 2007, Vol 25, Num 19, pp 2755-2763, issn 0732-183X, 9 p.Article

Hypoglycemia in the setting of advanced gastrointestinal stromal tumorGUITEAU, Jacfranz; FANUCCHI, Michael; FOLPE, Andrew et al.The American surgeon. 2006, Vol 72, Num 12, pp 1225-1230, issn 0003-1348, 6 p.Conference Paper

Selective serotonin reuptake inhibitor-induced rhabdomyolysis associated with irinotecanRICHARDS, Sarah; UMBREIT, Jay N; FANUCCHI, Michael P et al.Southern medical journal (Birmingham). 2003, Vol 96, Num 10, pp 1031-1033, issn 0038-4348, 3 p.Article

Farnesyl Transferase Expression Determines Clinical Response to the Docetaxel-Lonafarnib Combination in Patients With Advanced MalignanciesKAUH, John; CHANEL-VOS, Chantal; RAMALINGAM, Suresh S et al.Cancer. 2011, Vol 117, Num 17, pp 4049-4059, issn 0008-543X, 11 p.Article